期刊文献+

2型糖尿病患者骨矿含量的定量CT测定 被引量:2

Measurement of Bone Mineral Contents with QCT in Patients with NIDDM
暂未订购
导出
摘要 目的 研究 2型糖尿病患者的骨矿含量及其与病程、糖代谢控制程度和相关骨生化指标的关系。方法 6 6例分为三组。A组 2 0例 ,发病 2年以下。B组 2 6例 ,发病 8年以上。其中 B1 组 9例 ,空腹血糖 <7.8mm ol· L- 1 ;B2组 1 7例 ,空腹血糖 >7.8mmol· L- 1 。C组 2 0例 ,为正常对照组。6 6例均行腰椎 QCT,测定空腹血糖、血清钙、血清磷、ICTP及 BGP。结果  A组与 C组骨矿含量无显著差异 ;B组比 A、C组显著降低。 B2 组较 C组显著降低 ;B1 组与 C组、B2 组比较无显著差异。 ICTP与 BGP在三组间比较差异均无显著性。骨矿含量与 BGP和 ICTP无显著相关性。结论 初发病的男性患者骨矿含量并不降低 ;发病 8年以上的男性患者骨矿含量显著降低 ; Objective To clarify the questions whether bone mineral contents(BMC) in patients with NIDDM decreases or not; snd is there any correlation between BMC and the duration of NIDDM, sugar level and bone biochemical markers?Methods A total of 66 subjects were divided into three groups.: Group A, 20 patients with DM no longer than 2 years; Group B subdividing into B1, 9 patients with FBG<7.8 mmol/L and Group B 2,17 patients with FBG>7.8 mmol/L;Group C,20 healthy subjects.BMC by quantitative computed tomography(QCT),laboratory tests of FBG,Ca 2+ ,P 3+ ,ICTP and BGP were performed in all 66 subjects.Results BMC of Group B was significantly lower than that of Group A and Group C.BMCof subgroup B 2 was significantly lower than that of Group C. No correlation was found between BMC and ICTP or BGP.Conclusion BMC in patients with a duration less than 2 years was normal, while in patients longer than 8 years was significantly decreased. BMC has no correlation with ICTP and BGP.
出处 《上海铁道大学学报》 CAS 2000年第3期41-44,共4页
关键词 骨矿含量 定量CT Ⅱ型糖尿病 诊断 bone mineral content quantitative computed tomography(QCT) non insulin dependent diabetes mellitus (NIDDM) ICTP BGP
  • 相关文献

参考文献3

二级参考文献1

  • 1钱小毛,中华医学检验杂志,1984年,7卷,20页

共引文献32

同被引文献14

  • 1Shiomi S, Masaki K, Habu D, et al. Calcitriol for bone disease in patients with cirrhosis of the liver[J]. J Grastroenterol Hepatol, 1999,14(6) ~ 547 - 552.
  • 2Heathc O,Te J.Osteoporosis in chronic liver disease[J].Curr Gastroenterol Rep,1999,1(6):455-458.
  • 3Shiomi S,Nishiguchi S,Kurooka H,et al.Cyclical etidronate for treatment of.osteopenia in patients with cirrhosis of the liver[J].Hepatol Res,2002,22(2):102-106.
  • 4Guiehelaar MM,Malinchoc M,Sibonga J,et al.Bone metabolism in advanced cholestatic liver disease:analysis by bone histomorphometry[J].Hepatology,2002,36(4):895-903.
  • 5Trautwein.C, Possienke M, Schlitt HJ, et al. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation[J] .Am J Gastroenterol,2000,95(9) :2343 -2351.
  • 6廖二元 超楚生.内分泌学[M].北京:人民卫生出版社,2001.610-611.
  • 7Chan DL,Edelman SV,Chandran MO.Osteoporosis and diadetes[J].Curr Diab Rep,2003,3(1):37-42.
  • 8程萌 陈德才 卢春燕.骨质疏松与2型糖尿病.骨质疏松和骨矿盐疾病基础与临床,2006,5(2):120-121.
  • 9Gregorio F,Cristallini S,Santeusanio F,et al.Osteopenia associated with non-insulin dependent diabetes mellitus:what are the causes[J]? Diabetes Res Clin Pract,1994,23(1):43-54.
  • 10Wakasugi M,Wakao R,Tawaka M,et al.Bone mineral density measured by dual photon absorptiometry in patients with noninsulin-dependent diabetes mellitus[J].Bone,1993,4(1):29-34.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部